glp 1 kidney protection GLP-1 agonists in the treatment of chronic disease in type 2 diabetes and obesity GLP-1 receptor agonists and next-generation
Description
The HOMA-IR in the EGCG group decreased from 5.43.9 to 3.52.0 with statistical significance (p = 0.004), while that in the placebo group decreased from 5.94.5 to 4.73.4 without statistical significance
10.1016/S0140-6736(12)60479-6 25 GaoL.LeeB
You stay full longer
For women with PCOS, this sounds like a dream come true
Transfer to a jar or container and cover
November 24, 2023
